1. Novel agents in mantle cell lymphoma. Issue 6 (3rd June 2017) Authors: Tucker, David; Rule, Simon Journal: Expert review of anticancer therapy Issue: Volume 17:Issue 6(2017) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib. (12th May 2016) Authors: Tucker, David L.; Mihailescu, Loredana; Riordan, Richard; Rule, Simon Journal: British journal of haematology Issue: Volume 178:Number 1(2017) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The modern approach to mantle cell lymphoma. (12th June 2019) Authors: Rule, Simon Journal: Hematological oncology Issue: Volume 37(2019)Supplement 1 Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. Issue 2 (February 2016) Authors: Chanan-Khan, Asher; Cramer, Paula; Demirkan, Fatih; Fraser, Graeme; Silva, Rodrigo Santucci; Grosicki, Sebastian; Pristupa, Aleksander; Janssens, Ann; Mayer, Jiri; Bartlett, Nancy L; Dilhuydy, Marie-Sarah; Pylypenko, Halyna; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Villa, Diego; Samoil... Journal: Lancet oncology Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Issue 11 (November 2018) Authors: Thanarajasingam, Gita; Minasian, Lori M; Baron, Frederic; Cavalli, Franco; De Claro, R Angelo; Dueck, Amylou C; El-Galaly, Tarec C; Everest, Neil; Geissler, Jan; Gisselbrecht, Christian; Gribben, John; Horowitz, Mary; Ivy, S Percy; Jacobson, Caron A; Keating, Armand; Kluetz, Paul G; Krauss, Aviva... Journal: Lancet Issue: Volume 5:Issue 11(2018) Page Start: e563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017) Authors: Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J. S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Ta... Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rituximab administration in a community hospital environment. Issue 7 (July 2013) Authors: Shah, Nimish; Rule, Simon Journal: Leukemia & lymphoma Issue: Volume 54:Issue 7(2013:Jul.) Page Start: 1532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies. Issue 10 (24th August 2021) Authors: Jurczak, Wojciech; Rule, Simon; Townsend, William; Tucker, David; Sarholz, Barbara; Scheele, Jürgen; Dyroff, Martin; Gribben, John G.; Długosz-Danecka, Monika; Zinzani, Pier Luigi Journal: Leukemia & lymphoma Issue: Volume 62:Issue 10(2021) Page Start: 2392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Management perspective for mantle cell lymphoma. (February 2014) Authors: Shah, Nimish; Rule, Simon Journal: International journal of hematologic oncology Issue: Volume 3:Number 1(2014) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study. Issue 10020 (20th February 2016) Authors: Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D; Enny, Christopher; Traina... Journal: Lancet Issue: Volume 387:Issue 10020(2016) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗